Search Within

Maura N Dickler

Formats
  1. Meeting Abstract (141)
  2. Journal Article (115)
  3. Book Section (5)
  4. Conference Paper (1)
  5. Review (1)
Groups
  1. Department of Medicine (169)
  2. Solid Tumor Oncology Division (163)
  3. Breast Medicine Service (155)
  4. Survivorship Research (152)
  5. Epidemiology and Biostatistics (105)
  6. Population Sciences Research Program (89)

More Groups

People
  1. Clifford Hudis (102)
  2. Larry Norton (64)
  3. Shari Goldfarb (51)
  4. Chau Dang (39)
  5. Sujata Patil (35)
  6. Tiffany Traina (34)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2020 (6)
  4. 2019 (4)
  5. 2018 (20)
  6. 2017 (29)

More Years

Publications
  1. Journal of Clinical Oncology (69)
  2. Cancer Research (41)
  3. Breast Cancer Research and Treatment (18)
  4. Clinical Cancer Research (14)
  5. Annals of Oncology (10)
  6. Journal of Sexual Medicine (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (70)
  2. American Association for Cancer Research (57)
  3. Springer (26)
  4. Elsevier Inc. (18)
  5. Oxford University Press (18)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (263)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of BRCA mutations on chemotherapy-induced loss of ovarian reserve: A prospective longitudinal study
    Meeting Abstract

    Oktay, K.; Bedoschi, G.; Goldfarb, S. B.; Taylan, E.; Titus, S.; Palomaki, G. E.; Cigler, T.; Robson, M.; Dickler, M. N.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Evaluation and management of breast cancer
    Book Section

    Schleicher, S. M.; Dickler, M. N.
    In Stubblefield, M. D. (Eds.) Cancer Rehabilitation: Principles and Practice. 2nd ed (2019)

    Fulltext@MSK | Save
  • Sexuality and fertility
    Book Section

    Carter, J.; Goldfarb, S. B.; Sonoda, Y.; Nelson, C. J.; Dickler, M. N.; Mulhall, J. P.
    In The American Cancer Society (Eds.) The American Cancer Society's Principles of Oncology: Prevention to Survivorship (2018)

    Fulltext@MSK | Save
  • Updated efficacy, safety, & PD-L1 status of patients with HR+, HER2-metastatic breast cancer administered abemaciclib plus pembrolizumab
    Meeting Abstract

    Tolaney, S. M.; Kabos, P.; Dickler, M. N.; Gianni, L.; Jansen, V.; Lu, Y.; Young, S.; Rugo, H. S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Impact of abemaciclib on the time to subsequent chemotherapy and the time to second disease progression across the MONARCH 2 and 3 studies
    Meeting Abstract

    Tolaney, S. M.; Di Leo, A.; Llombart Cussac, A.; Dickler, M. N.; Campone, M.; Iwata, H.; Toi, M.; Kaufman, P. A.; Andre, V. A. M.; Barriga, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients
    Meeting Abstract

    Bao, T.; Seidman, A. D.; Piulson, L.; Chen, X.; Vickers, A. J.; Vertosick, E.; Blinder, V. S.; Zhi, W. I.; Li, Q. S.; Vahdat, L. T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Increased chemotherapy-induced ovarian reserve loss in women with BRCA mutations: A prospective longitudinal study with mechanistic confirmation
    Meeting Abstract

    Oktay, K.; Bedoschi, G.; Goldfarb, S.; Titus, S.; Palomaki, G.; Dickler, M.
    Fertility and Sterility (2018)

    Fulltext@MSK | Save
  • A rigorous evaluation of an institutionally-based communication skills program for post-graduate oncology trainees
    Journal Article

    Bylund, C. L.; Banerjee, S. C.; Bialer, P. A.; Manna, R.; Levin, T. T.; Parker, P. A.; Schofield, E.; Li, Y.; Bartell, A.; Chou, A.; more...
    Patient Education and Counseling (2018)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel and dasatinib in metastatic breast cancer
    Journal Article

    Morris, P. G.; Rota, S.; Cadoo, K.; Zamora, S.; Patil, S.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; more...
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • Phase II study of taselisib (GDC-0032) in combination with fulvestrant in patients with HER2-negative, hormone receptor-positive advanced breast cancer
    Journal Article

    Dickler, M. N.; Saura, C.; Richards, D. A.; Krop, I. E.; Cervantes, A.; Bedard, P. L.; Patel, M. R.; Pusztai, L.; Oliveira, M.; Cardenas, A. K.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save